Mark J. De Keijzer
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.
Journal: Biochemical pharmacology
Published: September 13, 2025
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.
Journal: Biochemical pharmacology
Published: September 13, 2025
Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 03, 2022
Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 03, 2022
Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: March 10, 2022
Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: October 31, 2020
Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
Journal: Journal of clinical and translational research
Published: February 02, 2020
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.
Journal: Journal of clinical and translational research
Published: February 15, 2019
The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 03, 2017
In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus.
Journal: Cancer gene therapy
Published: October 12, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026